According to the UALCAN database, GPR176 mRNA expression was higher in female than in male patients, and in Luminal and TNBC (triple-negative breast cancer) than in Her-2-positive cases, as well as in patients with nonmutant than mutant p53 (Fig. 1D, p < 0.05). The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.